Some of the key facts of the Clostridium Difficile Infections Market Report: ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Recurring Clostridioides difficile infections could be costing hospitals millions, an AtlantiCare Regional Medical Center study found. The study, published Sept. 29 in Cambridge Core, included 29 ...

The company said durable protection from a single dose is highly valuable, especially where vaccine access is limited.

Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population ...

SEATTLE — Autumn has arrived in the Pacific Northwest, meaning the long days and 90-degree temperatures are a thing of the past. Now, we can unpack the flannels, fleece, and rain gear and dust off our ...

CBS News on board as China intercepts Canadian air force mission Ex-QB Mark Sanchez now facing felony charge for altercation Supreme Court turns away Missouri’s bid to revive gun law Tim Curry’s wry ...

The FDA has approved leucovorin, a folic acid form, potentially aiding in treating autism symptoms. Formerly manufactured by GSK as Wellcovorin, it was withdrawn from the market earlier. Studies ...

TUESDAY, Sept. 23 2025 (HealthDay News) — Extreme pregnancy symptoms like excessive nausea and vomiting can dramatically increase a woman’s risk for mental health and neurological problems, a new ...

The U.S. Food and Drug Administration will soon approve leucovorin for children with cerebral folate deficiency and autism symptoms ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Due to the complexities of ...